BarbriSFCourseDetails
  • videocam On-Demand
  • signal_cellular_alt Intermediate
  • card_travel Health
  • schedule 90 minutes

Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact

$297.00

This course is $0 with these passes:

CLE
ALL
  1. keyboard_arrow_leftBack
BarbriPdBannerMessage

Description

Healthcare companies and providers regularly face supply chain-related challenges and associated risks as they navigate stringent regulations to ensure compliance. They now face additional challenges with a new administration imposing and/or proposing tariffs widely impacting the healthcare supply chain.

Healthcare companies, providers, and employees frequently interact with numerous vendors which presents risks if such vendors require access to patients or patient information. Healthcare companies and providers must carefully choose vendors, strategically negotiate and structure vendor contracts, and manage the relationship. Counsel must ensure that the contracts as well as the healthcare companies' and providers' policies and procedures related to dealing with vendors reduce the risk of vendor violations of federal and state regulations, including HIPAA and the Medicare Conditions of Participation.

In addition to understanding best practices for choosing and managing vendors, counsel should also understand the impact of tariffs being imposed and/or proposed by the new administration on the supply chain and contractual negotiations.

Listen as our authoritative panel of healthcare attorneys examines supply chain risks and what healthcare companies and providers need to do to mitigate those risks. The panel will discuss the policies and procedures to have in place; identifying and vetting vendors; negotiating, drafting, and managing supply chain contracts and how the new tariffs may affect this process; and more. The panel will also offer strategies for ensuring regulatory compliance.

Presented By

Monica Chmielewski
Partner, Vice Chair Health Care Practice Group
Foley & Lardner LLP

Ms. Chmielewski’s practice is solely focused on the representation of healthcare providers, pharmaceutical and medical device companies, and pharmacies in healthcare, healthcare transactions, clinical research, supply chain, and food and drug law. She provides daily counsel to numerous health systems, hospitals, academic medical centers, pharmacies, and biotech, pharmaceutical and medical device companies. Ms. Chmielewski regularly assists clients with the following issues: regulatory compliance governing all aspects of clinical research, investigations of research misconduct, Institutional Review Board issues, the conduct of U.S. and international clinical trials, research grants and funding, government investigations and audits, pharmaceutical product promotion (including counsel on off-label promotion), 510K applications, the regulation of software as a medical device, preparation of research contracts, among other matters.

expand_circle_down Expand to View Full Bio expand_circle_up Collapse Bio
Jenene R. Ebstein
Attorney
Foley & Lardner
Credit Information

  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Wednesday, July 23, 2025

  • schedule

    1:00 p.m. ET./10:00 a.m. PT

I. Introduction

II. Supply chain risks and healthcare companies

III. Mitigating supply chain risks

A. Policies and procedures to have in place

B. Vetting and selection of vendors

C. Identifying vendors as business associates

IV. Negotiating, drafting, and managing supply chain contracts

A. Insights into new and/or proposed tariffs and the potential impact on supply chains and contractual terms

V. Strategies for ensuring regulatory compliance

The panel will review these and other key issues:

  • What are the key supply chain risks facing healthcare companies and providers?
  • What questions should healthcare companies and providers ask during the supplier vetting process to minimize the likelihood of selecting a risky supplier?
  • What key terms should be negotiated in the supplier contract to help mitigate supply chain risks? How may these be impacted by the new administration's tariff policy?